BioMarin Pharmaceutical Inc. buy The Goldman Sachs Group, Inc.
Start price
05.05.25
/
50%
€54.86
Target price
05.05.26
€91.75
Performance (%)
-15.24%
Price
10.04.26
€46.50
Summary
This prediction is currently active. The prediction for BioMarin Pharmaceutical Inc. disappoints with a performance of -15.24%. This prediction currently runs until 05.05.26. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| BioMarin Pharmaceutical Inc. | -3.367% | -3.367% |
| iShares Core DAX® | 2.554% | 0.562% |
| iShares Nasdaq 100 | 2.742% | -0.599% |
| iShares Nikkei 225® | 6.584% | 4.336% |
| iShares S&P 500 | 1.930% | -0.507% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $124.00 to $104.00. They now have a "buy" rating on the stock.
Ratings data for BMRN provided by MarketBeat